Calidi Biotherapeutics (CLDI) Enterprise Value (2022 - 2025)
Calidi Biotherapeutics' quarterly Enterprise Value came in at -$219000.0 in Q4 2025, up 97.61% year-on-year from -$110825.3 in Q4 2024, and up 97.84% quarter-over-quarter from -$10.1 million in Q3 2025.
Calidi Biotherapeutics has reported Enterprise Value for 4 years, with the latest figure at -$219000.0 in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 97.61% year-over-year to -$219000.0; the trailing twelve-month figure through Dec 2025 stood at -$219000.0 (up 97.61% YoY), and the FY2025 full-year result was -$219000.0, up 97.61% from the prior year.
- Enterprise Value for Q4 2025 stood at -$219000.0, up from -$10.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$218000.0 in Q4 2022, with the low at -$10.2 million in Q1 2025.
- Average Enterprise Value over 4 years is -$3.5 million, with a median of -$1.1 million recorded in 2024.
- Year-over-year, Enterprise Value plunged 1943.97% in 2024 and soared 97.61% in 2025.
- Tracing CLDI's Enterprise Value over 4 years: stood at -$218000.0 in 2022, then plunged by 105.5% to -$448000.0 in 2023, then sank by 1943.97% to -$9.2 million in 2024, then soared by 97.61% to -$219000.0 in 2025.
- The last three Enterprise Value figures came in at -$219000.0 (Q4 2025), -$10.1 million (Q3 2025), and -$5.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -901.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -8.75 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | -18.44 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Calidi Biotherapeutics | - | - | - | -219,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -219,000.00 |
| Sep 30, 2025 | -10.12 Mn |
| Jun 30, 2025 | -4.99 Mn |
| Mar 31, 2025 | -10.24 Mn |
| Dec 31, 2024 | -9.16 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -836,000.00 |
| Mar 31, 2024 | -1.14 Mn |
| Dec 31, 2023 | -448,000.00 |
| Sep 30, 2023 | -218,000.00 |
| Dec 31, 2022 | -218,000.00 |